These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 562238)

  • 1. Nonspecific activation of murine spleen cells in vitro by a synthetic immunoadjuvant (N-acetyl-muramyl-L-alanyl-D-isoglutamine).
    Damais C; Parant M; Chedid L
    Cell Immunol; 1977 Nov; 34(1):49-56. PubMed ID: 562238
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-L-alanyl-D-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice.
    Damais C; Parant M; Chedid L; Lefrancier P; Choay J
    Cell Immunol; 1978 Jan; 35(1):173-9. PubMed ID: 563773
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement by muramyl dipeptide of in vitro nude mice responses to a T-dependent antigen.
    Leclerc C; Bourgeois E; Chedid L
    Immunol Commun; 1979; 8(1):55-64. PubMed ID: 311334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP).
    Löwy I; Leclerc C; Bourgeois E; Chedid L
    J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine).
    Lefrancier P; Derrien M; Lederman I; Nief F; Choay J; Lederer E
    Int J Pept Protein Res; 1978 Apr; 11(4):289-96. PubMed ID: 669885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures.
    Watson J; Whitlock C
    J Immunol; 1978 Jul; 121(1):383-9. PubMed ID: 307582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro responsiveness of immunocytes to a synthetic immunoadjuvant, muramyl dipeptide, and different synthetic analogs.
    Damais C; Parant M; Chedid L
    Antibiot Chemother (1971); 1978; 24():19-29. PubMed ID: 655676
    [No Abstract]   [Full Text] [Related]  

  • 11. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
    Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P
    Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
    Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
    Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses in vitro. V. Role of mercaptoethanol in the mixed-leukocyte reaction.
    Heber-Katz E; Click RE
    Cell Immunol; 1972 Nov; 5(3):410-8. PubMed ID: 4645593
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies.
    Audibert F; Heymer B; Gros C; Schleifer KH; Seidl PH; Chedid L
    J Immunol; 1978 Oct; 121(4):1219-22. PubMed ID: 701793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite modulation of lymph node cell and spleen cell responses to mitogens by muramyl dipeptide and its desmethyl analog.
    Brummer E; Stevens DA
    Cell Immunol; 1981 Mar; 59(1):195-204. PubMed ID: 7214544
    [No Abstract]   [Full Text] [Related]  

  • 17. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
    Souvannavong V; Adam A
    Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of N-acetyl-muramyl-L-alanyl-D-isoglutamine, an adjuvant of the immune response, and of some n-acetyl-muramyl-peptide analogs.
    Lefrancier P; Choay J; Derrien M; Lederman I
    Int J Pept Protein Res; 1977; 9(4):249-57. PubMed ID: 852928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific impaired alloreactivity of mice immunized with syngeneic MLCT-lymphoblasts using muramylpeptides as adjuvant.
    Binz H; Tarcsay L; Wigzell H; Dukor P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):566-73. PubMed ID: 6455801
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo.
    Staruch MJ; Wood DD
    J Immunol; 1982 Jan; 128(1):155-60. PubMed ID: 6976368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.